Skip to content
HeyJared

JASN Podcast

JASN publishes original research reports and basic and clinical science papers relevant to the broad discipline of nephrology. The JASN Podcast features discussions with authors of recently published articles.

Podcast · English · Official site

Indexed episodes, last 90 days
4
Latest publication
Sep 11, 2026
Audience
Checking…
Earliest in this view
Jul 28, 2026

Latest episodes

  1. Episode · Sep 11, 2026

    Barriers to Kidney Transplantation in the United States (opens the original)

    Episode notes

    Read excerpt

    Drs. Conor Donnelly, Michal A. Mankowski, and Allan B. Massie discuss the findings of their study, "Evaluating Barriers to Kidney Transplantation in the United States," with JASN Deputy Editor David H. Ellison and Junior Associate Editor Nathan H. Raines.

  2. Episode · Sep 2, 2026

    ASN Kidney Translation Series: ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome (opens the original)

    Episode notes

    Read excerpt

    This episode of ASN Kidney Translation Podcast explores the ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic (CKM) Syndrome, discussing key recommendations, risk assessment, and strategies to improve kidney, heart, and metabolic outcomes.

  3. Episode · Aug 6, 2026

    APOL1 at the Plasma Membrane and Cytotoxicity (opens the original)

    Episode notes

    Read excerpt

    Dr. Oyindamola Christiana Adebayo discusses the results of her study, "Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity," on behalf of her coauthors, with JASN Deputy Editor David H. Ellison.

  4. Episode · Jul 28, 2026

    ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances (opens the original)

    Episode notes

    Read excerpt

    ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about JASN Podcast